Chardan Healthcare Acquisition 2 (CHAQ) Stock Price, News & Analysis

Company Overview

Chardan Healthcare Acquisition 2 Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, stock purchase, recapitalization, reorganization, or other similar business combination. The company was incorporated in 2018 and is based in New York, New York.

Key Stats

• Today's Range: N/A
• 50-Day Range: $7.73 to $10.65
• 52-Week Range: N/A
• Volume: 14,313 shs
• Average Volume: 55,653 shs
• Market Capitalization: $34.49 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CHAQ Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Chardan Healthcare Acquisition 2 own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Chardan Healthcare Acquisition 2 investors own include Joint (JYNT), Avino Silver & Gold Mines (ASM), Actinium Pharmaceuticals (ATNM), Biomerica (BMRA), Churchill Capital Corp IV (CCIV), Clearside Biomedical (CLSD) and Gores Holdings IV (GHIV).

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Biological Products, Except Diagnostic
• Sub-Industry: N/A
• Current Symbol: NYSE:CHAQ
• CIK: N/A
• Web: www.chardanhealthcarespac.com
• Phone: 646-465-9000
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$780 thousand
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -81.39%
• Return on Assets: -0.75%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.13
• Quick Ratio: 0.13

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.54) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 10,778,000
• Free Float: N/A
• Market Cap: $34.49 million
• Optionable: Not Optionable
• Beta: 0.05